Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an update.
Recordati has engaged in transactions involving the sale and purchase of treasury shares. These transactions include the sale of shares to beneficiaries of stock option plans and the purchase of shares through a buy-back program executed by UBS Europe SE. This strategic move is likely aimed at optimizing capital structure and enhancing shareholder value.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica SPA is a pharmaceutical company based in Italy, specializing in the development, production, and marketing of pharmaceuticals. The company focuses on treatments for rare diseases and specialty pharmaceuticals, serving a global market.
Average Trading Volume: 321,413
Technical Sentiment Signal: Strong Buy
Current Market Cap: €11.09B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.